News & Updates

Analysing molecular signatures from active skin lesions aids in the stratification of patients with contact dermatitis (CD) and helps identify those with allergic CD, suggests a study.

Use of anlotinib combined with etoposide and carboplatin (EC; chemotherapy) as first-line therapy for patients with extensive-stage small cell lung cancer (ES-SCLC) yields a significantly improved progression-free survival (PFS) as well as overall survival (OS) benefits when compared with chemotherapy, according to data from the phase III ETER701 trial presented at ELCC 2024.

A recent study has shown the benefits of salt substitution in reducing all-cause or cardiovascular (CV) mortality. However, the evidence remains unclear as regards lowering CV events and not increasing serious adverse events, specifically in a Western population.